Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Vincenzo Serretta

Institute of Urology

University of Palermo

Palermo

Italy

[email]@libero.it

Name/email consistency: high

[Claim this account]

Affiliations

Institute of Urology, University of Palermo, Palermo, Italy. 2003 - 2010
Department of Internal Medicine, Cardiovascular and Nephro-Urological Diseases, University of Palermo, Italy. 2003 - 2008

References

A 1-year maintenance after early adjuvant intravesical chemotherapy has a limited efficacy in preventing recurrence of intermediate risk non-muscle-invasive bladder cancer. Serretta, V., Morgia, G., Altieri, V., Di Lallo, A., Ruggiero, G., Salzano, L., Battaglia, M., Falsaperla, M., Zito, A., Sblendorio, D., Melloni, D., Allegro, R. BJU Int. (2010) [Pubmed]
Cigarette smoking and drinking water source: correlation with clinical features and pathology of superficial bladder carcinoma. Serretta, V., Altieri, V., Morgia, G., Allegro, R., Ruggirello, A., Di Lallo, A., Carrieri, G., Melloni, D. Urol. Int. (2009) [Pubmed]
Oral chemotherapy in hormone-refractory prostate carcinoma patients unwilling to be admitted to hospital. Serretta, V., Altieri, V., Morgia, G., Siragusa, A., De Grande, G., Napoli, M., Falsaperla, M., Melloni, D., Allegro, R. Urol. Int. (2009) [Pubmed]
Optimizing intravesical chemotherapy in patient with non muscle invasive bladder carcinoma. Serretta, V. Arch. Ital. Urol. Androl (2008) [Pubmed]
PSA reduction (after antibiotics) permits to avoid or postpone prostate biopsy in selected patients. Serretta, V., Catanese, A., Daricello, G., Liotta, R., Allegro, R., Martorana, A., Aragona, F., Melloni, D. Prostate Cancer Prostatic Dis. (2008) [Pubmed]
Multiplicity and history have a detrimental effect on survival of patients with T1G3 bladder tumors selected for conservative treatment. Serretta, V., Ruggirello, A., Dispensa, N., Allegro, R., Aragona, F., Melloni, D. J. Urol. (2008) [Pubmed]
Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of bladder: Phase I-II study on marker lesions. Serretta, V., Galuffo, A., Pavone, C., Allegro, R., Pavone-MacAluso, M. Urology (2005) [Pubmed]
TUR and adjuvant intravesical chemotherapy in T1G3 bladder tumors: recurrence, progression and survival in 137 selected patients followed up to 20 years. Serretta, V., Pavone, C., Ingargiola, G.B., Daricello, G., Allegro, R., Pavone-Macaluso, M. Eur. Urol. (2004) [Pubmed]
Management of symptomatic benign prostatic hyperplasia in southern Italy: a retrospective analysis of the Sicilian-Calabrian Society of Urology (SSCU) of 32,000 patients. Serretta, V., Morgia, G., Fondacaro, L., Curto, G., Pirritano, D., Lo Bianco, A., Melloni, D., Orestano, F., Motta, M., Pavone-Macaluso, M. Urol. Int. (2003) [Pubmed]
Correlation between GP-170 expression, prognosis, and chemoresistance of superficial bladder carcinoma. Serretta, V., Pavone, C., Allegro, R., Vella, M., Sanguedolce, R., Porcasi, R., Morello, V., Tomasino, R.M., Pavone-Macaluso, M. J. Cancer Res. Clin. Oncol. (2003) [Pubmed]
Long-term outcome of antiandrogen monotherapy in advanced prostate carcinoma: 12-year results of a phase II study. Serretta, V., Daricello, G., Dispensa, N., Allegro, R., Pavone, C., Pavone-Macaluso, M. BJU Int. (2003) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.